Skip to menu Skip to content Skip to footer
Dr Adam Stewart
Dr

Adam Stewart

Email: 

Overview

Background

Adam G. Stewart, BBiomedSci, MBBS (Hons), MPHTM, FRACP, FRCPA

Dr Adam Stewart is an Infectious Diseases Physician, Clinical Microbiologist and Physician-Scientist.

His research interests include clinical trials, new antimicrobials, diagnostics for infectious diseases, and infections involving transplant recipients and other immunocompromised patients.

Availability

Dr Adam Stewart is:
Available for supervision
Media expert

Qualifications

  • Bachelor of Biomedical Science, Griffith University
  • Bachelor of Medicine and Surgery and Medical Science, Griffith University
  • Masters (Coursework) of Public Health and Tropical Medicine, James Cook University

Research interests

  • New Antimicrobials

    Pre-clinical and clinical research evaluating the efficacy of new antibacterial, antifungal and antiviral agents

  • Clinical Trials in Infectious Diseases

    Randomised controlled trials to identify better treatment options for the management of infectious diseases

  • Diagnostics in Infectious Diseases

    Evaluating the clinical utility of novel diagnostic platforms with regards to predicting risk of infection, pathogen identification and antimicrobial resistance testing

  • Infectious Complications in Transplant Recipients

    Improving surveillance, detection and management of infectious diseases in solid organ and haematopoietic stem cell transplant recipients

Works

Search Professor Adam Stewart’s works on UQ eSpace

88 works between 2015 and 2025

1 - 20 of 88 works

2025

Other Outputs

Treatment strategies for extended-spectrum beta-lactamase (ESBL) and AmpC-producing Enterobacterales

Stewart, Adam (2025). Treatment strategies for extended-spectrum beta-lactamase (ESBL) and AmpC-producing Enterobacterales. PhD Thesis, Faculty of Medicine, The University of Queensland. doi: 10.14264/28ac0b5

Treatment strategies for extended-spectrum beta-lactamase (ESBL) and AmpC-producing Enterobacterales

2025

Journal Article

Clinical Characteristics and Outcomes in Patients With Cryptococcaemia From a Large Population-Based Cohort

Stewart, Adam G., Laupland, Kevin B., Edwards, Felicity, Gassiep, Ian, Koo, Sophia, Hammond, Sarah P., Chen, Sharon C.-A. and Slavin, Monica A. (2025). Clinical Characteristics and Outcomes in Patients With Cryptococcaemia From a Large Population-Based Cohort. Mycoses, 68 (7) e70091, 7. doi: 10.1111/myc.70091

Clinical Characteristics and Outcomes in Patients With Cryptococcaemia From a Large Population-Based Cohort

2025

Journal Article

Differences in antimicrobial resistance gene abundance and microbial diversity of the gut microbiome in patients on antibiotics enrolled in a clinical trial

Stewart, Adam G., Harris, Patrick N. A., Graham, Rikki M. A., Jennison, Amy V., Schlebusch, Sanmarie, Kakkanat, Asha, Harris-Brown, Tiffany, Paterson, David L. and Forde, Brian M. (2025). Differences in antimicrobial resistance gene abundance and microbial diversity of the gut microbiome in patients on antibiotics enrolled in a clinical trial. Therapeutic Advances in Infectious Disease, 12 20499361251337597, 1-12. doi: 10.1177/20499361251337597

Differences in antimicrobial resistance gene abundance and microbial diversity of the gut microbiome in patients on antibiotics enrolled in a clinical trial

2025

Journal Article

Unravelling T Cell Immunity in CAR-T Therapy: Implications for Influenza Vaccination

Stewart, Adam G and Chemaly, Roy F (2025). Unravelling T Cell Immunity in CAR-T Therapy: Implications for Influenza Vaccination. Transplantation and Cellular Therapy, 31 (5), 282-284. doi: 10.1016/j.jtct.2025.04.003

Unravelling T Cell Immunity in CAR-T Therapy: Implications for Influenza Vaccination

2025

Journal Article

Population-based longitudinal study over two decades of Candida and Candida-like species bloodstream infection reveals gender and species differences in mortality, recurrence and resistance

Stewart, Adam G, Laupland, Kevin B, Edwards, Felicity, Koo, Sophia, Hammond, Sarah P, Harris, Patrick NA, Paterson, David L, Slavin, Monica A and Chen, Sharon C-A (2025). Population-based longitudinal study over two decades of Candida and Candida-like species bloodstream infection reveals gender and species differences in mortality, recurrence and resistance. Journal of Infection, 91 (1) 106513, 106513. doi: 10.1016/j.jinf.2025.106513

Population-based longitudinal study over two decades of Candida and Candida-like species bloodstream infection reveals gender and species differences in mortality, recurrence and resistance

2025

Journal Article

Population Pharmacokinetic Modelling of Remdesivir and Its Metabolite GS-441524 in Hospitalised Patients with COVID-19

Roberts, Darren M., Liu, Xin, Parker, Suzanne L., Burke, Andrew, Peek, Jenny, Carland, Jane E., Murnion, Bridin, Seah, Vincent, Wallis, Steven C., Sumi, Chandra D., Pandey, Saurabh, Buscher, Hergen, Byrne, Anthony, Sandaradura, Indy, Bowen, David, Holz, Simon, Stewart, Adam G., Hajkowicz, Krispin M. and Roberts, Jason A. (2025). Population Pharmacokinetic Modelling of Remdesivir and Its Metabolite GS-441524 in Hospitalised Patients with COVID-19. Clinical Pharmacokinetics, 64 (5) e0022222, 1-14. doi: 10.1007/s40262-025-01496-2

Population Pharmacokinetic Modelling of Remdesivir and Its Metabolite GS-441524 in Hospitalised Patients with COVID-19

2025

Journal Article

Community-onset bloodstream infection among people with opioid use disorders: a twenty-year population-based cohort study in Queensland, Australia

Laupland, Kevin B., Stewart, Adam G., Edwards, Felicity, Harris, Patrick N. A. and Coulter, Sonali (2025). Community-onset bloodstream infection among people with opioid use disorders: a twenty-year population-based cohort study in Queensland, Australia. Infectious Diseases, 57 (7), 669-675. doi: 10.1080/23744235.2025.2471823

Community-onset bloodstream infection among people with opioid use disorders: a twenty-year population-based cohort study in Queensland, Australia

2025

Journal Article

Primary graft dysfunction, dysbiosis, and innate immune activation after lung transplantation

Stewart, Adam G. and Chambers, Daniel C. (2025). Primary graft dysfunction, dysbiosis, and innate immune activation after lung transplantation. The Journal of Heart and Lung Transplantation, 44 (3), 435-436. doi: 10.1016/j.healun.2024.11.043

Primary graft dysfunction, dysbiosis, and innate immune activation after lung transplantation

2025

Journal Article

Klebsiella pneumoniae species complex bloodstream infection in adult patients: changing epidemiology and determinants of poor outcomes

Stewart, Adam G., Harris, Patrick N. A., Edwards, Felicity, Kiani, Behzad, Paterson, David L. and Laupland, Kevin B. (2025). Klebsiella pneumoniae species complex bloodstream infection in adult patients: changing epidemiology and determinants of poor outcomes. Infection, 53 (3), 1179-1187. doi: 10.1007/s15010-024-02457-w

Klebsiella pneumoniae species complex bloodstream infection in adult patients: changing epidemiology and determinants of poor outcomes

2025

Journal Article

Rezafungin acetate for the treatment of candidemia and invasive candidiasis: a pharmacokinetic evaluation

Bassetti, Matteo, Stewart, Adam, Bartalucci, Claudia, Vena, Antonio, Giacobbe, Daniele Roberto and Roberts, Jason (2025). Rezafungin acetate for the treatment of candidemia and invasive candidiasis: a pharmacokinetic evaluation. Expert Opinion On Drug Metabolism and Toxicology, 21 (2), 125-132. doi: 10.1080/17425255.2024.2424899

Rezafungin acetate for the treatment of candidemia and invasive candidiasis: a pharmacokinetic evaluation

2024

Journal Article

Risk of mortality in Fusobacterium species bloodstream infection from a large Australian cohort

Stewart, Adam G., Edwards, Felicity, Harris, Patrick N. A., Paterson, David L. and Laupland, Kevin B. (2024). Risk of mortality in Fusobacterium species bloodstream infection from a large Australian cohort. European Journal of Clinical Microbiology and Infectious Diseases, 44 (2), 427-436. doi: 10.1007/s10096-024-05012-5

Risk of mortality in Fusobacterium species bloodstream infection from a large Australian cohort

2024

Journal Article

<i>Yersinia enterocolitica</i> Pneumonia in a Heart Transplant Recipient

Portales Castillo, Carlos Alejandro, Stewart, Adam G. and Kotton, Camille N. (2024). Yersinia enterocolitica Pneumonia in a Heart Transplant Recipient. Transplant Infectious Disease, 27 (1) e14422, e14422. doi: 10.1111/tid.14422

<i>Yersinia enterocolitica</i> Pneumonia in a Heart Transplant Recipient

2024

Journal Article

Diagnosis and management of invasive fungal diseases by next-generation sequencing: are we there yet?

Babady, N. Esther, Chiu, Charles Y., Craney, Arryn, Gaston, David C., Hicklen, Rachel S., Hogan, Catherine A., John, Teny M. and Stewart, Adam G. (2024). Diagnosis and management of invasive fungal diseases by next-generation sequencing: are we there yet?. Expert Review of Molecular Diagnostics, 24 (12), 1083-1096. doi: 10.1080/14737159.2024.2436396

Diagnosis and management of invasive fungal diseases by next-generation sequencing: are we there yet?

2024

Journal Article

An update on recent clinical trial data in bloodstream infection

Stewart, Adam G., Simos, Peter, Sivabalan, Pirathaban, Escolà-Vergé, Laura, Garnham, Katherine, Isler, Burcu and ESGBIES Study Group (2024). An update on recent clinical trial data in bloodstream infection. Antibiotics, 13 (11) 1035, 1-14. doi: 10.3390/antibiotics13111035

An update on recent clinical trial data in bloodstream infection

2024

Journal Article

Elizabethkingia bloodstream infections in severely immunocompromised patients: persistent, relapsing and associated with high mortality

Fahmy, Mark, Stewart, Adam, Tey, Siok-Keen and Hajkowicz, Krispin (2024). Elizabethkingia bloodstream infections in severely immunocompromised patients: persistent, relapsing and associated with high mortality. JAC-Antimicrobial Resistance, 6 (5) dlae161, 1-5. doi: 10.1093/jacamr/dlae161

Elizabethkingia bloodstream infections in severely immunocompromised patients: persistent, relapsing and associated with high mortality

2024

Journal Article

Low rates of complications and β-lactam resistance in viridans group streptococci bloodstream infection among cancer patients receiving chemotherapy

Sheehy, Joshua, Scott, Ashleigh P., Henden, Andrea S., Kennedy, Glen, Redmond, Andrew M. and Stewart, Adam G. (2024). Low rates of complications and β-lactam resistance in viridans group streptococci bloodstream infection among cancer patients receiving chemotherapy. Journal of Antimicrobial Chemotherapy, 79 (8), 2040-2047. doi: 10.1093/jac/dkae209

Low rates of complications and β-lactam resistance in viridans group streptococci bloodstream infection among cancer patients receiving chemotherapy

2024

Journal Article

What's new: updates on cytomegalovirus in solid organ transplantation

Stewart, Adam G. and Kotton, Camille N. (2024). What's new: updates on cytomegalovirus in solid organ transplantation. Transplantation, 108 (4), 884-897. doi: 10.1097/TP.0000000000004855

What's new: updates on cytomegalovirus in solid organ transplantation

2024

Journal Article

Persistence of detectable pathogens by culture independent systems (T2 Magnetic Resonance) in patients with bloodstream infection: prognostic role and possible clinical implications

Peri, Anna Maria, O’Callaghan, Kevin, Rafiei, Nastaran, Graves, Bianca, Sinclair, Holly, Brischetto, Anna, Lim, Karen, Parkes-Smith, Jill, Eustace, Matthew, Davidson, Natalie, Tabah, Alexis, Stewart, Adam, Chatfield, Mark D., Harris, Patrick N.A. and Paterson, David L. (2024). Persistence of detectable pathogens by culture independent systems (T2 Magnetic Resonance) in patients with bloodstream infection: prognostic role and possible clinical implications. Clinical Infectious Diseases, 78 (2), 283-291. doi: 10.1093/cid/ciad663

Persistence of detectable pathogens by culture independent systems (T2 Magnetic Resonance) in patients with bloodstream infection: prognostic role and possible clinical implications

2024

Journal Article

Differences in antimicrobial resistance gene abundance and microbial diversity of the gut microbiome in patients on antibiotics enrolled in a clinical trial

Stewart, Adam G., Harris, Patrick N.A., Graham, Rikki M.A., Jennison, Amy V., Schlebusch, Sanmarie, Harris-Brown, Tiffany, Paterson, David L. and Forde, Brian M. (2024). Differences in antimicrobial resistance gene abundance and microbial diversity of the gut microbiome in patients on antibiotics enrolled in a clinical trial. Pathology, 56, S36-S37. doi: 10.1016/j.pathol.2023.12.137

Differences in antimicrobial resistance gene abundance and microbial diversity of the gut microbiome in patients on antibiotics enrolled in a clinical trial

2024

Journal Article

Impact of blood donation biovigilance and transfusion-transmitted infections on organ transplantation

Stewart, Adam G. and Kotton, Camille Nelson (2024). Impact of blood donation biovigilance and transfusion-transmitted infections on organ transplantation. Transplant Infectious Disease, 26 (Supplement 1) e14324, S1-S11. doi: 10.1111/tid.14324

Impact of blood donation biovigilance and transfusion-transmitted infections on organ transplantation

Funding

Current funding

  • 2020 - 2025
    COVID-19 Cure Research (Paterson)
    Royal Brisbane and Women's Hospital Foundation
    Open grant

Past funding

  • 2020 - 2022
    Assessing in vitro activity of oral third generation cephalosporin / beta-lactamase inhibitor combinations against extended spectrum beta-lactamase (ESBL) producing uropathogens
    The Royal College of Pathologists of Australasia
    Open grant
  • 2020 - 2021
    USE OF THERAPEUTIC DRUG MONITORING (TDM) TO OPTIMISE ORAL/ENTERAL HYDROXYCHLOROQUINE DOSING IN CRITICALLY ILL PATIENTS WITH COVID-19 (MRFF CRR Respiratory Medicine administered by QUT)
    Queensland University of Technology
    Open grant
  • 2020 - 2021
    Assessing the effects of new and old antibiotics on gut microbiota of hospitalized patients
    Avant Mutual Group Limited
    Open grant
  • 2020 - 2021
    Assessing the effects of new and old antibiotics on the gut microbiome of hospitalized patients
    Metro North Hospital and Health Service
    Open grant
  • 2019 - 2022
    A Multicentre, Parallel Group Open-label Randomised Controlled Non-Inferiority Phase 3 Trial, of ceftolozane-tazobactam versus meropenem for definitive treatment [...] MERINO-3
    Merck Sharp & Dohme Australia
    Open grant
  • 2018 - 2021
    A multicentre, Parallel Group Open-label RC Non-Inferiority Trial of piperacillin-tazobactam versus meropenem for definitive treatment of bloodstream infection due to AmpC-producing Enterobacterales
    Junior Doctor Research Fellowships
    Open grant

Supervision

Availability

Dr Adam Stewart is:
Available for supervision

Before you email them, read our advice on how to contact a supervisor.

Media

Enquiries

Contact Dr Adam Stewart directly for media enquiries about:

  • clinical trial
  • infectious diseases
  • superbugs

Need help?

For help with finding experts, story ideas and media enquiries, contact our Media team:

communications@uq.edu.au